“Mean Percent PASI Improvement With Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results from Four Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s55. Accessed May 16, 2025. https://skin.dermsquared.com/skin/article/view/1406.